Related Experiment Video
Updated: Jun 12, 2026

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
Published on: May 14, 2018
Temporal proteome profiling of taxol-induced mitotic arrest and apoptosis
Vibeke H Bull1, Ellen M Fargestad, Margarita Strozynski
1The Biotechnology Centre of Oslo, University of Oslo, Oslo, Norway.
Abstract:
Taxol (Paclitaxel) is a mitotic inhibitor widely used in cancer therapy. Temporal proteome profiling was performed to study changes of proteins during the different cellular states of HeLa cells caused by exposure to taxol. The changes of proteins over time could be associated with various cellular processes such as mitotic arrest, an intermediate between mitotic arrest and apoptosis, apoptosis, and late apoptosis. Calumenin, stress-induced phosphoprotein 1 (STIP1), and translationally controlled tumor protein (TCTP) were assigned to mitotic arrest and selected for further experiments using immunoblotting and subcellular fractionation. Calumenin translocated from membranes to the cytosol during mitotic arrest and late apoptosis, but was significantly reduced in the cytosol during apoptosis. Translocation of STIP1 to the nucleus was observed at apoptosis and to the cytoskeleton at late apoptosis. TCTP increased in the cytosol at mitotic arrest and in membranes at apoptosis. In addition, the quantitative time courses of Bim isoforms revealed differences between BimL and BimS in comparison with BimEL. In summary, temporal proteome profiling of HeLa cells incubated with taxol allowed the assignment of proteins to certain processes and additional experiments with complementary approaches enabled a more comprehensive understanding of spatial changes of selected proteins during mitotic arrest and apoptosis.
Insights
Taxol (Paclitaxel) treatment causes protein changes in HeLa cells, revealing spatial shifts in Calumenin, STIP1, and TCTP during mitotic arrest and apoptosis. These findings enhance understanding of cancer therapy mechanisms.
Area of Science:
- Cell Biology
- Cancer Research
- Proteomics
Background:
- Taxol (Paclitaxel) is a key mitotic inhibitor in cancer therapy.
- Understanding protein dynamics during drug-induced cellular states is crucial.
Purpose of the Study:
- To investigate temporal proteome changes in HeLa cells exposed to Taxol.
- To identify and characterize protein translocations during mitotic arrest and apoptosis.
Main Methods:
- Temporal proteome profiling of HeLa cells.
- Immunoblotting and subcellular fractionation for specific proteins.
- Quantitative analysis of Bim isoforms.
Main Results:
- Calumenin, STIP1, and TCTP showed distinct subcellular localization changes during Taxol treatment.
- Calumenin shifted from membranes to cytosol, STIP1 translocated to the nucleus/cytoskeleton, and TCTP localized to cytosol/membranes.
- Differential expression of Bim isoforms (BimL, BimS, BimEL) was observed.
Conclusions:
- Temporal proteome profiling effectively assigns proteins to cellular processes like mitotic arrest and apoptosis.
- Complementary methods revealed spatial protein dynamics crucial for understanding Taxol's mechanism of action.
- This study provides insights into the complex cellular responses to Taxol therapy.

